| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |